Filter
1728
Filtered Results: 1728
Text search:
generics
Featured
Recommendations
169
New Publications
435
Language
Document type
No document type
989
Guidelines
258
Studies & Reports
239
Manuals
115
Strategic & Response Plan
57
Training Material
26
Fact sheets
23
Situation Updates
10
Infographics
4
Brochures
3
Resource Platforms
2
Online Courses
2
Countries / Regions
Global
77
India
73
Nepal
34
Kenya
33
Ethiopia
33
South Africa
32
Western and Central Europe
29
Nigeria
26
Uganda
25
Tanzania
24
Liberia
24
Myanmar / Burma
22
Sierra Leone
20
Latin America and the Carribbean
20
Bangladesh
20
Ghana
19
Malawi
19
Zambia
19
Ukraine
18
Africa
18
Rwanda
17
Namibia
13
Syria
11
Zimbabwe
11
Eastern Europe
11
Indonesia
11
Burkina Faso
10
Philippines
10
South–East Asia Region
10
Cambodia
8
Asia
8
Eswatini/ Swaziland
8
East and Southern Africa
7
Lesotho
6
Russia
6
Cameroon
5
Senegal
5
Guinea
5
West and Central Africa
5
Sri Lanka
5
Thailand
4
Benin
4
Mozambique
4
Haiti
4
Germany
4
Congo, Democratic Republic of
4
Western Pacific Region
4
Vietnam
4
Botswana
4
Albania
3
Middle East and North Africa
3
North America
3
Sudan
3
Pakistan
3
Tajikistan
2
Laos
2
Afghanistan
2
Venezuela
2
Jordan
2
Eastern Europe and Central Asia
2
Paraguay
2
Brazil
2
South Sudan
2
Iraq
2
North Macedonia
1
North Korea
1
Switzerland
1
Colombia
1
Timor Leste/ East Timor
1
Mexico
1
Turkey
1
China
1
Chile
1
Iran
1
Fiji
1
Burundi
1
Peru
1
Morocco
1
Bulgaria
1
Saudi Arabia
1
France
1
Mauritius
1
Tunisia
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Argentina
1
Lebanon
1
Greece
1
Georgia
1
Bhutan
1
Somalia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
532
Clinical Guidelines
169
Public Health
129
Key Resources
116
Women & Child Health
79
Capacity Building
38
Pharmacy & Technologies
34
Toolboxes
HIV
164
Mental Health
121
COVID-19
101
Pharmacy
92
AMR
78
TB
70
Rapid Response
54
Disability
53
Planetary Health
43
NTDs
43
NCDs
42
Ebola & Marburg
40
Conflict
40
Caregiver
34
Global Health Education
28
Specific Hazards
24
Natural Hazards
23
Health Financing Toolbox
17
Refugee
16
Zika
10
Polio
9
Social Ethics
7
Cholera
4
Malaria
4
The Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020 by the World Health Organization (WHO) outlines a comprehensive strategy to address the global rise in noncommunicable diseases (NCDs), including cardiovascular diseases, cancer, chronic respiratory diseases,...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co...
Submitted to the US Agency for International Development by the
Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.
This manual provides a framework to identify problems and design interventions to improve access to and use of medicines for children. It is a resource for ...
Minimizing risk of developing antibiotic resistance and aquatic ecotoxicity in the environment resulting from the manufacturing of human antibiotic.
The Standard, facilitated by BSI Standards Limited (BSI), provides clear guidance to manufacturers in the global antibiotic supply chain to ensure t...
Examining the infrastructure of the Russian and USA healthcare systems with respect to the management of HIV patients
An analysis from the perspective of the health sector in Latin America and the Caribbean
Washington, D.C., 2017
Kenya national palliative care guidelines
recommended
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities ...
Effective implementation of WHO PEN, combined with other very cost effective population-wide interventions, will help even resource constrained settings to attain the global voluntary targets related to reduction of premature mortality and preventionof heart attacks and strokes.
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and ...
SHOPS and HIA finalized a scope of work with USAID Senegal in April 2015, and a team of five private sector experts conducted the onsite assessments between May and June 2015. The Private Sector Assessment (PSA) team worked closely with Senegalese key stakeholders throughout the process. The PSA tea...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
